Comparison of Hemodialysis With Medium Cut-off Dialyzer (Theranova) and High Flux Dialyzer (THERANOVA)

This is an interventional other trial for End Stage Renal Disease focused on measuring dialyzer, beta2-microglobilin, myoglobin Read More

Inclusion Criteria:

• Age ≥ 18 years
• Patient suffering from chronic terminal renal failure excluding nephropathy with myelomatous cylinders, hemodialysis for more than 6 months,
• Patient under dialyser Elisio-21H ™ for more than 3 months
• Patient including the protocol scheme and able to comply with it
• Free subject, without guardianship or curatorship or subordination
• Patients benefiting from a Social Security scheme or benefiting from it through a third party
• Non-opposition given by the patient after clear and fair information on the study

Exclusion Criteria:

• Age <18 years
• Patient with an associated pathology (evolutionary cancer, progressive infectious disease or chronic inflammatory disease) that may excessively influence CRP levels (CRP> 60 mg / L)
• Patient following another protocol of research or period of exclusion of another protocol
• Patients not benefiting from a Social Security scheme or not benefiting from it through a third party
• Persons benefiting from enhanced protection, namely minors, persons deprived of their liberty by a judicial or administrative decision, persons staying in a health or social institution, adults under legal protection, and finally patients in emergencies .
• Pregnant or nursing women, women of childbearing age who do not have effective contraception (hormonal / mechanical: oral, injectable, transcutaneous, implantable, intrauterine device, or surgical: tubal ligation, hysterectomy, total ovariectomy ).